- /
- Supported exchanges
- / US
- / PTN.NASDAQ
Palatin Technologies, Inc. Common Stock (PTN NASDAQ) stock market data APIs
Palatin Technologies, Inc. Common Stock Financial Data Overview
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Palatin Technologies, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Palatin Technologies, Inc. Common Stock data using free add-ons & libraries
Get Palatin Technologies, Inc. Common Stock Fundamental Data
Palatin Technologies, Inc. Common Stock Fundamental data includes:
- Net Revenue: 12 884 K
- EBITDA: -8 752 423
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Palatin Technologies, Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-09-16
- EPS/Forecast: NaN
Get Palatin Technologies, Inc. Common Stock End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Palatin Technologies, Inc. Common Stock News
New
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It
Rare-endocrine buyers have paid roughly $2.9 billion and approximately $10.0 billion for acquisitions in this area over the past four months. IMCIVREE, the only approved MC4R agonist for acquired hypo...
Transcript: Palatin Techs Q3 2026 Earnings Conference Call
Palatin Techs (AMEX:PTN) held its third-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcri...
Palatin Technologies GAAP EPS of -$0.37, revenue of $3.9M
* Palatin Technologies press release [https://seekingalpha.com/pr/20512993-palatin-reports-fiscal-third-quarter-2026-financial-results-and-provides-business-update] (PTN [https://seekingalpha.com/sy...
This High-Flying Growth Stock Is Hiding in Plain Sight
There's a growth stock that has skyrocketed more than Google parent Alphabet(NASDAQ: GOOG)(NASDAQ: GOOGL) and Nvidia(NASDAQ: NVDA) over the last 12 months. Wall Street loves this stock, with the conse...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.